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INTRODUCTION
' The purpose of this study is to support Russian space flight experiments carried out on rats flown
aboard Space Shuttle Mission SLS-2. The Russian experiments were designed to determine the effects
of space flight on immunological parameters. The Russian experiment included the first in-flight
dissection of rodents that allowed the determination of kinetics of when space flight affected immune
responses.
The support given the Russians by this laboratory was to a carry out assays for immunologically
important cytokines that could not readily be carried out in their home laboratories. These included assays
of interleukin-1, interleukin-6, interferon-gamma and possibly other cytokines. All data will be made
available-to the Russian investigator, Dr. Andre Lesnyak of the Institute of Biomedical Problems.
METHODS, RESULTS AND DISCUSSION
In the first six months of this study, we have received supernatant fluids from cells from rats flown
aboard the Space Shuttle mission SLS-2. Samples received include supernatants from controls, rats
flown in space and dissected in space and rats flown in space and dissected upon return to earth.
Production of interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumor necrosis factor-alpha,
tumor necrosis factor-beta, interferon-alpha, interferon-gamma was examined. Also, the activity of natural
killer cells was examined. The data are included in detailed in the appended tables and manuscript. In
summary, changes in immunological parameters were shown to be occurring in cells obtained from in-flight
dissections of rats. This is the first time this has been demonstrated. For some immunological parameters,
these alterations persisted after flight, but for others there was a return to normal values after flight.
For the first time, it has now been demonstrate that changes in immune response occur during
flight, and not just immediately after flight. This could indicate that microgravity could play a role in the
alterations in immune responses induced by space flight.
PUBLICATIONS
1. Lesnyak, A., Sonnenfeld, G., Avery, L, Konstantinova, I., Rykova, M., Meshkov, D., and Orlova, T.
Effects of SLS-2 Space Flight on Immunological Parameters of Rats. J. Appli Physiol., In Revision, 1995.
(Appended to this report).
SLS-2 BSP Rat Experiment
Spleen and bone marrow ceil cultures stimulated with 1ua/ml of ConA and assaved for levels of IL-4
spleen samples
sample ID final cone, ng/ml
flight 1 6.84E-14
flight 2 9.23E-14
flights 1.02E-13
flight 4 3.57E-13
flights 1.68E-14
flight Ctrl 1 6.84E-14
flight Ctrl 2 7.19E-14
flight Ctrl 3 6.18E-14
flight ctrl 4 7.19E-14
flight Ctrl 5 1.68E-13
recovery 1 9.70E-15
recovery 2 2.64E-14
recovery 3 1.25E-14
recovery 4 1.38E-14
recovery 5 2.16E-14
rec. Ctrl 1 0.0014483
rec. Ctrl 2 0.0048151
rec. ctrl 3 0.0277638
rec. Ctrl 4 0.0374898
rec. Ctrl 5 0.0087797
adaptation ! 0.020561
adaptation J 0.0374898
adaptation^ 0.0356594
adaptation^ 0.0718657
adaptations, 0.0394142
bone marrow samples
sample ID
basal Ctrl 1
basal ctrl 2
basal ctrl 3
basal Ctrl 4
basal ctrl 5
recovery 1
recovery 2
recovery 3
recovery 4
recovery 5
rec. ctrl 1
rec. ctrl 3a
rec. Ctrl 3b
rec. ctrl 4
rec. ctrl 5
adaptation *
adaptation ?
adaptation U
adaptation 5
adapt, ctrl 1
adapt, ctrl 2
adapt, ctrl 3
adapt. Ctrl 4
adapt, ctrl 5
final cone, ng/ml
5.10E-14
9.45E-14
3.85E-13
1.85E-13
4.07E-13
1.57E-13
5.39E-13
1.75E-13
3.44E-14
8.45E-14
1.57E-13
4.56E-13
1.57E-13
3.25E-14
7.55E-14
7.14E-12
1.06E-12
1.32E-12
6.03E-13
6.75E-13
3.64E-13
2.75E-13
1.18E-13
3.64E-13
*^ &r\r * **>
blank 0.0006836
blank 0.0003392
** adapt, ctrl and basal samples
were mislabelled and therefore were
not used * *
negative Ctrl 2.60E-13
** rec.ctrl did not have sample
#2, but had two #3, they were
labelled 3a arid 3b and used,
adapt, did not have sample #1 *
SLS-2 BSP Rat Experiment
Spleen and bone marrow cell cultures stimulated with 1ua/ml of LPS and assaved for levels of IL-6
spleen samples
sample ID
basal Ctrl
basal Ctrl
basal Ctrl
basal Ctrl
basal Ctrl
flight 1
flight 2
flight 3
flight 4
flight 5
flight Ctrl
flight Ctrl
flight Ctrl
flight Ctrl
flight Ctrl
recovery
recovery
recovery
recovery
recovery
rec Ctrl 1
rec Ctrl 2
rec Ctrl 3
rec Ctrl 4
rec Ctrl 5
adapt 1
adapt 2
adapt 3
adapt 4
adapt 5
adapt ctr!
adapt Ctrl
adapt Ctrl
adapt Ctrl
adapt ctrl
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
1
2
3
4
5
final cone, ug/ml
172.18613
149.6126
66.978926
30.056484
28.373191
8.5280196
5.4434995
4.611882
25.052334
8.8480627
4.7736238
12.242728
16.63061
9.6584666
30.825362
1.15.60275
35.804546
32.878211
5.4564249
21.180596
98.848065
18.618221
116.94945
144.54337
29.306785
17.455736
27.987762
7.9599104
15.203311
9.7478353
97.043885
20.179397
151.35549
96.382496
78.704247
bone marrow samples
sampleJD
basal ctrl 1
basal ctrl 2
basal Ctrl 3
basal ctrl 4
basal Ctrl 5
recovery 1
recovery 2
recovery 3
recovery 4
recovery 5
rec. ctrl 1
rec. ctrl 2
rec. ctrl 3
rec. ctrl 4
rec. ctrl 5
adapt. 1
adapt. 2
adapt. 3
adapt. 4
adapt. 5
adapt, ctrl 1
adapt, ctrl 2
adapt. Ctrl 3
adapt, ctrl 4
adapt. Ctrl 5
final cone, ug/ml
2
2
8
1
2
5
8
5
5
6
3
0
0
3
2
2
1
1
2
4
1
2
4
.4485455
.9710378
.2023477
2.031787
.1373082
3.318243
.4485455
.3203252
.3548408
.2715481
.6746382
.8062545
.5804546
.9770981
.8052638
.9083925
.8771876
.0089456
1.532891
.7497185
.9985285
.4252537
1.747303
.7346905
.7087776
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ABSTRACT
During the Space Shuttle SLS-2 mission rats were dissected in space
and biosamples were returned to the Earth for analysis. Immunological studies
addressed the kinetics of T-lymphocyte proliferative responses, cytotoxic activity of
natural killer cells, and cytokine production. Experiments were performed using spleen
and bone marrow of rats dissected before flight, during flight, immediately after
recovery (R) or 14 days after recovery (R + 14), as well as respective control
animals. Each group consisted of 5 Sprague-Dawley male rats. It was demonstrated that
T-lymphocyte activity of rats dissected in flight was significantly decreased when
compared to the controls. This was observed during 48-, 72- and 96-hour cultivation
and stimulation with the following mitogenic stimuli: concavalin A (Con A) 0.1, 1.0, and
10.0 mg/ml, phytohemagglutinin (PHA) 2.5 mg/ml, and interleukin-2 (IL-2) 1 U/ml.
The proliferative response returned to normal only in PHA stimulated cultures after an
extended 96-hour cultivation. The cell proliferation rate in rats dissected immediately
after recovery did not decrease, while that in rats dissected at R+14 increased. The
activity of spleen natural killer cells was reduced in response to 51cr-labeled target
cells during flight (YAC-1 and K-562) and after flight (YAC-1). At R+14, their
activity returned to normal. Another technique employed to measure natural
cytotoxicity, using ^H-uridine labeled target cells and RNase, did not reveal any
differences between control and experimental groups. In bone marrow, the activity of
natural killer cells did not vary significantly. The production of interleukin-1 (IL-1),
IL-2, tumor necrosis factor - alpha (TNF-alpha) and tumor necrosis factor - beta
(TNF-beta) in spleen cell cultures of the flight rats was reduced. At R+0, IL-1 and
TNF-beta remained lowered, while TNF-alpha was increased. At R+0, interferon-alpha
(IFN-alpha) and interferon-gamma (IFN-gamma) were diminished. In summary, cell-
mediated immunity in rats was drastically suppressed during flight. The time course
variation of immune parameters after flight suggests that the changes may truly indicate
a response of the immune system to space flight conditions that could increase over time.
Space flight, T-lymphocytes, natural killers, immunity parameters, cytokines
INTRODUCTION
It has been demonstrated that exposure of animals and humans to microgravity
caused, as a rule, immune alterations detected immediately after flight [3-7, 9, 10, 12,
14, 1 5]. Immune changes mainly consisted of decreases in the proliferative activity of
T-lymphocytes [4-6, 8-10], cytotoxic activity of natural killer cells [6, 9-11 ], and
production of cytokines [2, 6, 9-11 ]. Spaceflight was also found to have an impact on
the distribution of immunocompetent cells [6, 8, 12, 14, 15] and bone marrow cell
sensitivity to the colony forming factors [12, 13].
SLS-2 was the first flight in which rats were dissected in orbit and biosamples
returned to the Earth for analysis. This made it possible to obtain unique data about
cell-mediated immunity of rats during space flight without having to consider landing
stresses.
The purpose of this experiment was to assess spaceflight effects on
cell-mediated immunity in orbit and the pattern of its recovery after flight.
The objectives of the experiment were:
1. To study spaceflight effects on the kinetics of lymphocyte proliferation,
2. to assess the activity of natural killer cells,
3. to investigate the production of cytokines, i.e., interleukin-1
(IL-1), interleukin-2 (IL-2), interferons- (IFN) alpha and gamma, and tumor
necrosis factors- (TNF) alpha and beta.
MATERIALS AND METHODS
Biosamples were obtained from 15 Sprague-Dawley male rats, which weighed
approximately 300 g on the dissection day and were flown for 14 days on SLS-2.
Twenty ground-based control animals were kept in an environment mocking that in orbit
with respect to the diet and water consumption, air temperature and humidity, and
light-dark cycle.
The experimental animals formed the following groups:
Basal control group (BC) 5 rats
Group dissected in flight (F) 5 rats
Ground-based control group to F rats (FC) 5 rats
Flight rats dissected immediately after recovery (R+0) 5 rats
Ground-based control group to R+0 rats (RC+0) 5 rats
Flight rats dissected 14 days after recovery (R+14) 5 rats
Ground-based control group to R+14 rats (RC+14) 5 rats
Spleen and bone marrow cells from the rats were used for our experiments. Cell
suspensions were prepared at the dissection site and shipped at +4 °C to NASA Ames
Research Center. Arrival time at the Ames Research cCenter was about 12 hr after
termination of the dissections. Immediately upon receipt, cells were cultured. Cell
viability measured by trypan blue dye exclusion was not less than 80 - 90%.
Cell suspensions were stored and shipped in McCoy's 5A (Sigma) culture media
supplemented with L-glutamine, HEPES-buffer, fetal bovine serum, and antibiotics.
Lymphocyte proliferation activity and natural killer cytotoxicity were measured using
RPMI-1640 media (Sigma) that also contained L-glutamine, fetal bovine serum, and
antibiotics. Cytokine production was assessed on Iskove media (Sigma) containing L-
glutamine and antibiotics.
Parameters measured in the experiment.
Proliferative activity _ of Concavalin A (Sigma) (Con A 0.1, 1.0, and 10.0
mg/ml), phytohemagglutinin (Sigma) (PHA 2.5 mg/ml), and interleukin-2 (Sigma)
(IL-2, 1.0 U/ml) stimulated spleen T-cells was measured in terms of DMA synthesis
(^H-thymidine incorporation during 18 hours) after 48, 72 and 96 hours of
cultivation at 37 °C in humidified 5% C02 air. The cell concentration was
0.2 X 10^ cells/well of a round-bottom culture plate in each of two arrays. After
incubation, cell residues were placed onto filters using a cell harvester, and their
radioactivity was measured by means of a liquid scintillation counter. Results were
expressed as distintegrations per minute (dpm).
Activity of natural killer cells _ found in spleen and bone marrow was assayed on
YAC-1 and K-562 cultured target cells labeled with 51Cr and 3H-uridine.The effector:
target ratios used were: 100: 1, 50: 1, 25: 1, 12: 1, 6: 1, 3:1, and 1.5: 1 (10,000
target cells per well). In ^ H-uridine tests, effector cells were treated with actinomycin
D (Sigma) (5 mg/ml) for 1 hour at 37 °C and the reaction conducted in the presence of
ribonuclease A (Sigma) containing culture media to prevent label re-utilization. Cell
cultures were incubated for 4 hours in 51Cr tests and for 16 hours in ^H-uridine tests
in humidified 5% C02 air at 37 °C. After incubation in cultures containing ^H-uridine
labeled target cells, residues were transferred onto filters using a cell harvester, and
their radioactivity was measured by means of a liquid scintillation counter. Results
were expressed as a cytotoxicity index equal to (1 - dpm in experiment / dpm in
control) X 100. In cultures containing 51 Cr labeled target cells, the supernatant fluid
was collected, and its radioactivity was measured by means of a gamma-counter. Results
were expressed as a cytotoxicity index equal to ((dpm in experiment - dpm in control) /
(maximum dpm in supernatant - dpm in control)) X 100.
Cvtokines were assessed in supernatant fluids of spleen and bone marrow cells
cultivated in 24-well flat-bottom plates in humidified 5% C02 air at 37 °C at a
7concentration of 5 X 106 cells / 1.5 ml/ well. After incubation, supernatant fluids
were frozen and stored at -20 °C until testing.
Interleukin -1 (IL-T). _ Spleen and bone marrow cells were incubated for
24 hours in the presence of E. coli lipopolysaccharide (LPS) (Sigma) (1 mg/ml) in
humidified 5% C02 air at 37 °C.Supernatant activity was measured in 72-hour cell
cultures of C3H/HeJ murine thymus (2 month old males). Serial supernatant dilutions
(two per dilution) were added to the wells of a 96-well plate containing 1.5 X 106
thymus cells. The reaction was measured in terms of ^H-uridine incorporation during
the last 18 hours of incubation. Cell residues were transferred onto filters using a cell
harvester, and their radioactivity was measured by means of a liquid scintillation
counter. Results were compared with standard IL-1 (lnterleukin-1 alpha, Cytokine
Science Inc.) and expressed as U/ml.
Interleukin -2 (IL-2). _ Spleen cells were incubated for 48 hours in the presence
of Con A (1 mg/ml). lnterleukin-2 activity was measured in CTLL-2 cell culture for
48 hours in humidified 5% COz air at 37 °C. Supernatant fluids were serially diluted
(two per dilution). The reaction was measured in terms of
3|H-uridine incorporation during the last 18 hours of incubation. Cell residues were
transferred onto filters using a cell harvester, and their radioactivity was measured by
means of a liquid scintillation counter. Results were compared
with standard IL-2 (T-cell growth factor, Sigma) and expressed as U/ml.
Interferon-alpha (IFN-alpha). _ Spleen cells were incubated for 24 hours in the
presence of poly-l:C (polyinosinic-polycytidylic acid, Sigma) (25 mg/ml) and DEAE-
dextrane (Sigma) (50 mg/ml).
Interferon-gamma (IFM-gamma). _ Spleen cells were incubated for 48 hours in
the presence of Con A (1 mg/ml).
Interferon activity was measured in cultured murine L-cells with respect
8to the suppression of the cytopathic effect of murine encephalomyocarditis virus.
Supernatant fluids diluted with the test cell culture were incubated for 24 hours
in humidified 5% C02 air at 37 °C. Results were expressed as In titer (units/ml).
Tumor necrosis factor - alpha (TNF-alpha^ _. Spleen cells were cultivated
for 24 hours in the presence of LPS (10 ng/ml) and muramyl dipeptide (MDP,
10 mg/ml) (Adjuvant peptide, Sigma).
Tumor necrotic factor - beta (TNF-beta). From a spleen cell suspension,
a nonadherent fraction was isolated by incubating the suspension in Petri dishes (60
min) in humidified 5% C02 air at 37 °C. Nonadherent cells were cultivated for 48 hours
in the presence of Con A (1 mg/ml).
TNF-alpha and TNF-beta activities were measured with respect to their
cytopathic effect on L929 cells. Cells were incubated for 14 hours with serially diluted
supernatant fluids containing TNF-alpha and TNF-beta; then dead cells were identified,
and viable cells were stained with crystal violet. The titer of TNF was the reciprocal
last dilution of test sample that decreased viability by 50%. Results were compared
with standard TNF-alpha and TNF-beta (Sigma).
The resultant data were treated statistically to determine mean arithmetic (M)
and standard error (m). The difference between flight and control groups
of rats was evaluated using the Student's t-test (t) and nonparametric Wilcoxon-Mann-
Whitney test (U).
RESULTS
Proliferative activity .
Basal controls showed a high level of T-lymphocyte proliferation during
different cultivation times and with different mitogen concentrations used.
The proliferative activity of spleen T-lymphocytes sacrificed in flight
(Figure 1) was reduced in both unstimulated cultures and in cultures stimulated with
various concentrations of Con A, PHA and IL-2 during 48-, 72- and 96-hour
incubation. The response returned to the control level only in PHA stimulated cultures
cultivated for 96 hours.
In R+0 animals, spontaneous proliferative activity decreased slightly in
48- and 72-hour cultures.
At R+14, 48-hour cultures showed increases in spontaneous proliferative
activity and in responses to stimulation with Con A (0.1 and 1.0 mg/ml) and IL-2, when
compared to the controls; 72-hour cultures showed a higher response to PHA
stimulation; 96-hour cultures had the same level of proliferative activity as controls.
Functional activity of natural killers.
Spleen cells
Test with 51 Cr-labeled target cells.
In cell cultures with YAC-1 (Figure 2) of F and R+0 rats, the functional activity
of natural killer cells was decreased in the case of most effector: target ratios used. At
R+14, cytotoxic activity was fully recovered. In cell cultures with K-562 (Figure 3)
of F rats, cytotoxicity index was significantly decreased at ratios of 1: 100, 1: 50, 1: 12
and 1: 6. No marked differences were seen in R+0 and R+14 groups.
Test with 3H-uridine labeled target cells.
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In the test with 3H-uridine labeled target cells changes were smaller. In cell
cultures with YAC-1, the cytotoxicity index was lowered in F rats at a ratio
of 1: 3 and in R+0 rats at ratios of 1: 3 and 1: 1.5. The cytotoxicity index was,
on the contrary, increased in R+14 rats at a ratio of 1: 1.5. In cell cultures with
K-562, functional activity was decreased in F rats at a ratio of 1: 50 and in R+0 rats at
ratios of 1: 100 and 1: 50. The cytotoxicity index in R+0 rats was increased at a ratio of
1: 1.5. At R+14, no changes were detected.
Bone marrow cells.
Test with 51 Cr labeled target cells.
In YAC-1 and K-562 cell cultures no significant differences were found between
flight and control animals. The only exception was a decreased cytotoxicity index in R+0
rats identified in K-562 cultures at ratios of 1: 25 and
1:6.
Test with ^H-uridine labeled target cells.
No significant differences were observed with respect to YAC-1 and
K-562.
Cvtokines (Table 1)
lnterleukin-1
The ability of spleen cells to produce IL-1 was diminished in F and R+0 rats. No
differences were seen in R+14 rats. IL-1 activity in supernatant fluids
of bone marrow cells was low , being very similar in flight animals and their respective
controls.
lnterleukin-2
The ability of spleen cells to produce IL-2 remained high in basal controls. This
parameter was not determined in F rats and was not detectable in their controls. In R+0
and R+14 rats, the parameter did not differ from the controls.
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Interferon-alpha.
IFN-alpha activity in supernatant fluids of spleen cell cultures of F and
R+0 rats remained very close to that in the controls, and in R+14 rats it was decreased.
Interferon-gamma.
IFN-gamma production by spleen cells was high in basal controls. The parameter
was not determined in supernatant fluids of F rats or their controls. The parameter in
R+0 rats was the same as in the controls, and in R+14 rats
it was lowered.
Tumor necrotic factor - alpha.
TNF-alpha production by spleen cells was decreased in F rats and increased in
R+0 rats, when compared to their controls. At R+14, no significant changes were
observed.
Tumor necrotic factor - beta.
TNF-beta production by spleen cells was decreased in F and in R+0 rats, when
compared to their controls. At R+14, no significant changes were found.
DISCUSSION
Our investigations demonstrated significant changes in immune responses of rats,
when tissues were harvested during flight. The rats dissected in orbit showed a marked
decline of the spleen lymphocyte capability to proliferate in response to mitogenic
stimulation during all cultivation times. The data obtained for the first time ever by in
vitro cell cultivation techniques that indicated a significant decrease of the functional
activity of T-lymphocytes in space flight could yield difficulties in the formation of a
specific immune response. The fact that flight rat cells recovered their capability of
responding to one of the mitogens used, i.e. PHA, when the incubation time was increased
12
to 96 hours, gave evidence that the changes could be transient. This was supported by
the observation that the proliferative activity of spleen stimulated cells of flight rats
dissected at R+0 was very similar to that of controls. Additionally, IL-2 activity was
reduced only in flight rats, which was consistent with a proliferation rate decrease
observed at that time. Changes detected in R+0 and R+14 rats were
in agreement with immunological observations on SLS-1 rats (A. Lesnyak,
G. Sonnenfeld, unpublished data).
Measurement of cytotoxic activity also yielded interesting data. The function of
spleen natural killers was significantly inhibited. The test with 51 Cr- labeled target
cells demonstrated a significant decrease of the cytotoxicity index of F rats in relation to
both YAC-1 and K-562 cells, and that of R+0 rats in relation to YAC-1 cells. The
parameter returned to normal at R+14. The test with 3H-uridine labeled target cells
showed less substantial changes in spleen natural killers. Bone marrow natural killers
varied insignificantly. Cosmos rat experiments revealed a decreased activity of spleen
natural killers in the test with 51Cr- labeled target cells [11 ].
The production of cytokines also varied significantly in space. IL-1 activity in
cultured spleen cells was diminished in F and R+0 rats. TNF-alpha and TNF-beta in
cultured spleen cells was also lowered in F rats. At R+0, TNF-beta remained decreased
while TNF-alpha increased. In F rats, IFN-alpha remained unaltered. At R+0, IFN-
alpha and IFN-gamma production was identical to that in the controls and at R+14 it was
reduced. It should be noted that similar changes in the cytokine production were found in
the SLS-1 rat experiment (A. Lesnyak, G. Sonnenfeld, unpublished data). However,
Cosmos experiments yielded different results [8]. At R+0, IL-1 production was
increased and IL-2 decreased. IFN-gamma activity was also reduced in both Cosmos [8]
and SL-3 [2] experiments.
In summary, SLS-2 experiments provided new data about spaceflight effects on
immune responses. Proliferative activity and natural cytotoxicity of spleen cells, as
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well as IL-1, IL-2, TNF-alpha and TNF-beta production were decreased in orbit. IFN-
alpha remained unaltered. After flight most immune parameters returned to normal. At
R+0, spontaneous lymphocyte proliferation, natural cytotoxicity in the 51Q--YAC-1
test, and IL-1 and TNF-beta production remained at a lower level; however, TNF-alpha
was increased. At R+14, proliferative activity tended to increase and interferon
production to decrease.
No significant changes were found in cultured bone marrow cells. In our opinion, the
discrepancy between Cosmos and SLS results can be attributed to differences in flight
conditions. Those would include a less stressful SLS landing profile, earlier animal
dissection after SLS flight, and differences between Wistar and Sprague-Dawley rat
strains. These assumptions require experimental verification.
Of crucial importance is the fact that immunological studies were performed on
animals dissected in orbit for the first time ever. Changes seen can be qualified as
significant immune alterations. However, immune data can be properly interpreted only
in relation to biochemical, morphological and hormonal observations. In spaceflight, the
suppression of immunocompetent cell populations was selective rather than total. At
R+14, readaptation of the immune system was not yet complete, indicating that 14 days
was an insufficient time period for all the immune parameters to return to normal. In
any case, it is now clear that immune alterations observed in space can be attributed
directly to spaceflight conditions.
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CAPTIONS TO FIGURES
Figure 1. ^H-thymidine incorporation into mitogen stimulated spleen cell cultures
(from left to right: no stimulation, Con A - 0.1 mg/ml, Con A - 1.0 mg/ml, Con A -
10.0 mg/ml, PHA -- 2.5 mg/ml, and IL-2 - 1 U/ml).
Figure 2. Cytotoxic activity of spleen natural killer cells toward ^  Cr-labeled target
cells YAC-1 (from left to right effector: target ratio - 1: 100, 1: 50, 1: 25,
1: 12, 1:6, 1: 3, 1: 1.5).
Figure 3. Cytotoxic activity of spleen natural killer cells toward 51 Cr-labeled target
cells K-562 (from left to right effector: target ratio - 1: 100, 1: 50, 1: 25,
1: 12, 1:6, 1: 3, 1: 1.5).
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